BOT-3 Prognostic Factors of CNS Germ Cell Tumors; Molecular and Histopathological Analyses on 154 Cases from the iGCT Consortium. (6th December 2021)

• Record Type: Journal Article
• Authors: Takami, Hirokazu; Satomi, Kaishi; Fukuoka, Kohei; Matsushita, Yuko; Yamasaki, Kai; Nakamura, Taishi; Kanamori, Masayuki; Tominaga, Teiji; Tanaka, Shota; Mukasa, Akitake; Saito, Nobuhito; Suzuki, Tomonari; Yanagisawa, Takaaki; Nakamura, Hideo; Sakai, Keiichi; Sugiyama, Kazuhiko; Tamura, Kaoru; Maehara, Taketoshi; Nakada, Mitsutoshi; Nonaka, Masahiro; Asai, Akio; Yokogami, Kiyotaka; Takeshima, Hideo; Iuchi, Toshihiko; Kanemura, Yonehiro; Kobayashi, Keiichi; Nagane, Motoo; Kurozumi, Kazuhiko; Yoshimoto, Koji; Matsuda, Masahide; Matsumura, Akira; Hirose, Yuichi; Tokuyama, Tsutomu; Kumabe, Toshihiro; Narita, Yoshitaka; Shibui, Soichiro; Nakazato, Yoichi; Nishikawa, Ryo; Matsutani, Masao; Ichimura, Koichi;
• Is Part Of: Neuro-oncology advances. Volume 3(2021)Supplement 6
• Page Start: vi8
• Page End: vi9
• Publication Date: 2021-12-06
• Subjects: Germ cell tumor -- Tumor cell content -- 12p gain; 616.99481
• DOI: 10.1093/noajnl/vdab159.031
• Languages: English
• ISSNs: 2632-2498

Abstract

Abstract: Background: Germ cell tumors (GCTs) preferentially occurs in pediatric and young adult age groups. Chemo- and radiation therapies cause long-term sequelae in their later lives. We searched for clinical and histopathological features to predict the prognosis and affect treatment response, with a future goal of treatment stratification.Methods: A total of 154 GCT cases were included in the analysis. Total of 114 germinoma cases underwent measurement of tumor cell content on H-E specimen, and 82 GCT cases underwent 450K methylation analysis. 12p gain was determined on methylation-based copy number computation and FISH. Association with progression-free and overall survival (PFS/OS) was investigated. Results: The tumor cell content was widely distributed from <5% to 90% in the specimens, with a median value of 50%. Patients with a higher tumor cell content (>=50%) showed shorter PFS than those with a lower tumor cell content (<50 %) (p=0.03). In the multivariate analysis with tumor location, tumor cell content was the sole statistically significant prognostic factor (p=0.04). 12p gain was found in 25-out-of-82 cases (30%) and was more frequent in NGGCTs, particularly in cases with malignant components. The presence of 12p gain correlated with shorter PFS and OS, even with histology and tumor markers incorporated in the multivariate analysis. Among NGGCTs, 12p gain still had prognostic significance for PFS and OS. The 12p copy number status was shared among histological components in mixed GCTs. Whole-genome amplification was suggested by FISH.Conclusions: We found that tumor cell content significantly affected the prognosis of germinomas. 12p gain predicts the presence of malignant components of NGGCTs, and poor prognosis of the patients. Furthermore, 12p is likely to be an early event in the tumorigenesis of CNS GCT. These potentially open the possibility of leveraging these pathological and molecular factors in the future clinical trials when stratifying the treatment intensity.